Tamsulosin in urology: beyond benign prostatic hyperplasia

G. G. Laxman Prabhu; Hiren Prajapati; Alok Chaturvedi; Nilanj Dave; Amit B. Jain

doi:10.1007/s40267-019-00611-1

Tamsulosin in urology: beyond benign prostatic hyperplasia

G. G. Laxman Prabhu^*
, Hiren Prajapati
, Alok Chaturvedi
, Nilanj Dave
, Amit B. Jain

^*Corresponding author for this work

Department of Urology, Kasturba Medical College, Mangalore

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Tamsulosin, a third-generation uroselective α _1A adrenergic receptor blocker (antagonist), has been approved for the treatment of signs and symptoms of benign prostatic hyperplasia for more than two decades. Apart from this approved use, more recent evidence has been published regarding the off-label use of tamsulosin in various other urological conditions. However, further research is needed regarding the use of tamsulosin in these indications. This review highlights the possible therapeutic uses of tamsulosin for the management of various urological conditions.

Original language	English
Pages (from-to)	181-184
Number of pages	4
Journal	Drugs and Therapy Perspectives
Volume	35
Issue number	4
DOIs	https://doi.org/10.1007/s40267-019-00611-1
Publication status	Published - 10-04-2019

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Access to Document

10.1007/s40267-019-00611-1

Cite this

@article{90b2b64fabc3444f90602969ceb0ab54,

title = "Tamsulosin in urology: beyond benign prostatic hyperplasia",

abstract = " Tamsulosin, a third-generation uroselective α 1A adrenergic receptor blocker (antagonist), has been approved for the treatment of signs and symptoms of benign prostatic hyperplasia for more than two decades. Apart from this approved use, more recent evidence has been published regarding the off-label use of tamsulosin in various other urological conditions. However, further research is needed regarding the use of tamsulosin in these indications. This review highlights the possible therapeutic uses of tamsulosin for the management of various urological conditions. ",

author = "\{Laxman Prabhu\}, \{G. G.\} and Hiren Prajapati and Alok Chaturvedi and Nilanj Dave and Jain, \{Amit B.\}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Switzerland AG.",

year = "2019",

month = apr,

day = "10",

doi = "10.1007/s40267-019-00611-1",

language = "English",

volume = "35",

pages = "181--184",

journal = "Drugs and Therapy Perspectives",

issn = "1172-0360",

publisher = "Adis",

number = "4",

}

TY - JOUR

T1 - Tamsulosin in urology

T2 - beyond benign prostatic hyperplasia

AU - Laxman Prabhu, G. G.

AU - Prajapati, Hiren

AU - Chaturvedi, Alok

AU - Dave, Nilanj

AU - Jain, Amit B.

PY - 2019/4/10

Y1 - 2019/4/10

N2 - Tamsulosin, a third-generation uroselective α 1A adrenergic receptor blocker (antagonist), has been approved for the treatment of signs and symptoms of benign prostatic hyperplasia for more than two decades. Apart from this approved use, more recent evidence has been published regarding the off-label use of tamsulosin in various other urological conditions. However, further research is needed regarding the use of tamsulosin in these indications. This review highlights the possible therapeutic uses of tamsulosin for the management of various urological conditions.

AB - Tamsulosin, a third-generation uroselective α 1A adrenergic receptor blocker (antagonist), has been approved for the treatment of signs and symptoms of benign prostatic hyperplasia for more than two decades. Apart from this approved use, more recent evidence has been published regarding the off-label use of tamsulosin in various other urological conditions. However, further research is needed regarding the use of tamsulosin in these indications. This review highlights the possible therapeutic uses of tamsulosin for the management of various urological conditions.

UR - https://www.scopus.com/pages/publications/85062948883

UR - https://www.scopus.com/pages/publications/85062948883#tab=citedBy

U2 - 10.1007/s40267-019-00611-1

DO - 10.1007/s40267-019-00611-1

M3 - Review article

AN - SCOPUS:85062948883

SN - 1172-0360

VL - 35

SP - 181

EP - 184

JO - Drugs and Therapy Perspectives

JF - Drugs and Therapy Perspectives

IS - 4

ER -

Tamsulosin in urology: beyond benign prostatic hyperplasia

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this